Ciprofloxacin Use in the Enterally Fed Patient

Nutrition in Clinical Practice

Volumn 14, Issue 2, 1999, Pages 73-77

  Nyffeler, Michael S ^a  

^a MERITER HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992827704     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/088453369901400206     Document Type: Article

References (16)

1. Fass RJ. Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. Antimicrobial Agents and Chemotherapy 1987; 31: 148–50.
2. Powers T, Bingham DH. Clinical and economic effect of ciprofloxacin as an alternative to injectable antimicrobial therapy. Am J Hosp Pharm 1990; 47: 1781–4.
3. Cooke J, Cairns CJ, Tillotson GS, et al. Comparative clinical, microbiologic, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials. Ann Pharmacother 1993; 27: 785–9.
4. Forrest A, Nix DE, Ballow CH, et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents Chemotherapy 1993; 37: 1073–81.
5. Hoflken G, Borner K, Glatzel PD, et al. Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur J Clin Microbiol 1985; 3: 345.
6. Deppermann KM, Lode H. Fluoroquinolones. Interaction profile during enteral absorption. Drugs 1993; 45(Suppl 3):65–72.
7. Noer BL, Angaran DM. The effect of enteral feedings on ciprofloxacin pharmacokinetics. Pharmacother 1990; 10: 254 [Abstract].
8. Piccolo ML, Toossi Z, Goldman M. Effect of coadministration of a nutritional supplement on ciprofloxacin absorption. Am J Hosp Pharm 1994; 51: 2697–9.
9. Healy DP, Brodbeck MC, Clendening CE. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes. Antimicrobial Agents Chemotherapy 1996; 40: 6–10.
10. Mueller BA, Brierton DG, Abel SR, et al. Effect of enteral feeding with Ensure on oral bioavailabilities of ofloxacin and ciprofloxacin. Antimicrobial Agents Chemotherapy 1994; 38: 2101–5.
11. Yuk JH, Nightingale CH, Sweeney KR, et al. Relative bio-availability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding. Antimicrobial Agents Chemotherapy 1989; 33: 1118–20.
12. Marie SD, VandenBergh MFQ, Buijk SLCE, et al. Bioavailability of ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram-negative intra-abdominal infections. Intensive Care Med 1998; 24: 343–6.
13. Cohn SM, Sawyer MD, Burns GA, et al. Enteric absorption of ciprofloxacin during tube feeding in the critically ill. J Antimicrobial Chemotherapy 1996; 38: 871–6.
14. Yuk JH, Nightingale CH, Quintiliani R, et al. Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutrition. Diagn Microbiol Infec Dis 1990; 33: 99–102.
15. Staib AH, Beermann D, Harder S, et al. Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). Am J Med 1989; 87(Suppl 5A):66S-69S.
16. Cohn SM, Cohn KA, Rafferty MJ, et al. Enteric absorption of ciprofloxacin during the immediate postoperative period. J Antimicrobial Chemotherapy 1995; 36: 717–21.